Compugen Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
34.32 M |
Public Float |
- |
Compugen Ltd. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.55 |
Market Cap |
$227.03 M |
Shares Outstanding |
59.9 M |
Public Float |
54.76 M |
Address |
Azrieli Center Holon TA 58858 Israel |
Employees | - |
Website | http://www.cgen.com |
Updated | 07/08/2019 |
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |